Also, the demonstration of the feasibility of MT1-MMP as biomarker for tumor progression, able to discriminate between real and pseudoprogression after standard treatments, would be of great relevance for evaluating MT1-MMP-specific antibodies as non-invasive diagnostic tools in clinic. The gene discussed is MMP14; the disease is neoplasm.